Active Ingredient(s): Flortaucipir F-18
FDA Approved: * May 28, 2020
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tauvid Overview

Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain.[1][2][3] The most common adverse reactions include headache, injection site pain and increased blood pressure.[1][2] Two proteins – tau and amyloid – are recognized as hallmarks of Alzheimer's disease.[1] In people ...

Read more Tauvid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Flortaucipir_(18F)

Recent Tauvid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Flortaucipir F-18
  • Solution: 30ml (8.1-51mci/ml), 50ml (8.1-51mci/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tauvid: (1 result)

Sorted by National Drug Code
  • 0002-1210 Tauvid 51 mci/Ml Intravenous Injection, Solution by Eli Lilly and Company

Other drugs which contain Flortaucipir F-18 or a similar ingredient: (1 result)